Ness, Nils-Henning
Schriefer, Dirk
Haase, Rocco
Ettle, Benjamin
Ziemssen, Tjalf
Article History
First Online: 4 May 2020
Change Date: 13 May 2020
Change Type: Correction
Change Details: In the original version of this article, the title of the article has been published incorrectly.
Compliance with Ethical Standards
:
: NHN has received funding for research from Novartis. DS has nothing to disclose. RH has received speaker fees from Sanofi and travel grants from Celgene. BE is an employee of Novartis. TZ received personal compensation from Almirall, Biogen, Bayer, Celgene, Novartis, Roche, Sanofi, and Teva for consulting and speaking services, and he is the section editor for <i>BMC Neurology</i>. Additionally, he received financial support for research activities from BAT, Biogen Novartis, Teva, and Sanofi.
: Approval for PANGAEA and PEARL were obtained from independent, local, competent ethics committees.
: All patients provided written informed consent for the collection of clinical and health economic information.